Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / LUMO - Lumos Pharma Inc. (LUMO) CEO Richard Hawkins on Q1 2022 Results - Earnings Call Transcript

LUMO - Lumos Pharma Inc. (LUMO) CEO Richard Hawkins on Q1 2022 Results - Earnings Call Transcript

Lumos Pharma Inc.
Lumos Pharma, Inc. (LUMO) Q1 2022 Earnings Conference Call May 10, 2022, 16:30 ET Company Participants Lisa Miller - Senior Director, IR Richard Hawkins - CEO & Chairman John McKew - Chief Scientific Officer & President David Karpf - Chief Medical Officer Lori Lawley - CFO & Principal Accounting Officer Conference Call Participants Avraham Novick - Cantor Fitzgerald & Co. Yasmeen Rahimi - Piper Sandler & Co. Catherine Novack - JonesTrading Institutional Services Edward White - H.C. Wainwright & Co. Presentation Operator Good afternoon, and welcome to Lumos Pharma's First Quarter 2022 Results & Clinical Update Conference Call. [Operator Instructions]. As a reminder, this conference call is being recorded. I'd now like to turn the call over to Lisa Miller, Senior Director of Investor Relations. Please go ahead. Lisa Miller Thank you, Operator. Before we proceed with the call, I would like to remind everyone that certain statements made during

For further details see:

Lumos Pharma, Inc. (LUMO) CEO Richard Hawkins on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Lumos Pharma Inc.
Stock Symbol: LUMO
Market: NASDAQ
Website: lumos-pharma.com
Menu
LUMO LUMO Quote LUMO Short LUMO News LUMO Articles LUMO Message Board
Get LUMO Alerts

News, Short Squeeze, Breakout and More Instantly...